Country Trust Bank’s Moderna MRNA Stock Holding History

Country Trust Bank’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.3K	Hold	318	–	–	﹤0.01%	272
2026 Q1	$16.2K	Hold	318	–	–	﹤0.01%	278
2025 Q4	$9.38K	Hold	318	–	–	﹤0.01%	341
2025 Q3	$8.21K	Hold	318	–	–	﹤0.01%	363
2025 Q2	$8.77K	Hold	318	–	–	﹤0.01%	322
2025 Q1	$9.02K	Hold	318	–	–	﹤0.01%	251
2024 Q4	$13.2K	Hold	318	–	–	﹤0.01%	244
2024 Q3	$21.3K	Hold	318	–	–	﹤0.01%	221
2024 Q2	$37.8K	Hold	318	–	–	﹤0.01%	178
2024 Q1	$33.9K	Hold	318	–	–	﹤0.01%	187
2023 Q4	$31.6K	Sell	318 -250	-44%	-$21K	﹤0.01%	184
2023 Q3	$58.7K	Hold	568	–	–	﹤0.01%	161
2023 Q2	$69K	Hold	568	–	–	﹤0.01%	151
2023 Q1	$87.2K	Hold	568	–	–	﹤0.01%	139
2022 Q4	$102K	Buy	568 +150	+36%	+$24.5K	﹤0.01%	139
2022 Q3	$49K	Hold	418	–	–	﹤0.01%	177
2022 Q2	$60K	Hold	418	–	–	﹤0.01%	177
2022 Q1	$72K	Hold	418	–	–	﹤0.01%	181
2021 Q4	$106K	Sell	418 -156	-27%	-$45.6K	﹤0.01%	169
2021 Q3	$221K	Sell	574 -743	-56%	-$274K	0.01%	124
2021 Q2	$309K	Hold	1,317	–	–	0.01%	114
2021 Q1	$172K	Hold	1,317	–	–	0.01%	135
2020 Q4	$138K	Buy	1,317 +982	+293%	+$99.3K	﹤0.01%	140
2020 Q3	$24K	Hold	335	–	–	﹤0.01%	200
2020 Q2	$22K	Hold	335	–	–	﹤0.01%	187
2020 Q1	$10K	Buy	+335	New	+$7.71K	﹤0.01%	218

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Country Trust Bank's MRNA Position: Q2 2026 in Review

Country Trust Bank held its Moderna (MRNA) position steady in Q2 2026 at 318 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Country Trust Bank first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $309K in Q2 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Country Trust Bank held 318 shares of Moderna worth $22.3K as of Q2 2026.
Country Trust Bank left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of Country Trust Bank's portfolio in Q2 2026, its #272 holding.
Country Trust Bank first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
Country Trust Bank's Moderna position peaked at $309K in Q2 2021.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.